Bristol Myers Squibb to acquire Orbital Therapeutics for USD1.5bn to expand cell therapy portfolio
Celltrion launches AVTOZMA IV in the United States following FDA approval
OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
EMA recommends marketing approval of Alvotech's Gobivaz biosimilar to Simponi
Nanjing Leads Biolabs receives FDA approval of IND application for LBL-047
J & D Pharmaceuticals receives Orphan Drug Designation for JD-004
Hemogenyx reports positive safety and early efficacy data from third patient in CAR-T trial
Forte Biosciences highlights positive FB102 data in celiac disease at Tampere Symposium
Hemogenyx Pharmaceuticals partners with Made Scientific to advance CAR-T therapy
Onco3R Therapeutics receives Belgian regulatory approval for clinical trial of novel SIK3 inhibitor
ImmuPharma files patent for P140 'Immunormalizer' with precision diagnostic for autoimmune diseases
Coya Therapeutics wins FDA clearance to advance COYA 302 into Phase 2 ALS trial
Bio-Thera and STADA expand biosimilars partnership to include tocilizumab